Topics

FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

23:36 EDT 15 Aug 2019 | FDA

FDA approves third cancer treatment based on a common biomarker across different types of tumors rather than the location in the body where the tumor originated

Original Article: FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

NEXT ARTICLE

More From BioPortfolio on "FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor"

Quick Search

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...